This article by High Times explores a study at the University of Calgary which aims to shed light on the potential for psilocybin in treating alcohol use disorder. Researchers are recruiting 128 participants in the largest single-site trial of its kind in Canada. The trial will study Filament's botanical psilocybin drug candidate, PEX010.
Recent News
Study Aims To Determine Role of Shrooms in Battling Alcoholism
High Times
March 22, 2024